跳至主要内容
临床试验/IRCT20190224042818N1
IRCT20190224042818N1招募中3 期

Investigation of the Effect of Curcumin on Preventing Anthracycline-Induced Cardiomyopathy in Patients with Breast Cancer - A Randomized Clinical Trial Study

Mashhad University of Medical Sciences0 个研究点目标入组 40 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • Patients with breast cancer who planned for antracycline-based chemotherapy

排除标准

  • presence of cardiomyopathy (dilated, restrictive or hypertro-phic) detected by baseline echocardiography
  • Past medical history of coronary heart disease
  • Moderate or severe aortic and/or mitral valve disease
  • Prior chemotherapy or radiotherapy,
  • Alcohol abuse
  • Any contraindications to Curcumin
  • Patients on other cardiac medications such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, non-dihydropyridine calcium channel blockers, diuretics, statins or beta-blockers

研究者

相似试验